Imperial College London

ProfessorSebastianJohnston

Faculty of MedicineNational Heart & Lung Institute

Asthma UK Clinical Chair
 
 
 
//

Contact

 

+44 (0)7931 376 544s.johnston

 
 
//

Assistant

 

Mr Christophe Tytgat +44 (0)20 7594 3849

 
//

Location

 

343Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Kumar:2020:10.5644/ama2006-124.292,
author = {Kumar, K and Singanayagam, A and Johnston, SL},
doi = {10.5644/ama2006-124.292},
journal = {Acta Med Acad},
pages = {130--143},
title = {Respiratory Virus Infections in Asthma: Research Developments and Therapeutic Advances.},
url = {http://dx.doi.org/10.5644/ama2006-124.292},
volume = {49},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - In this review, we discuss the latest developments in research pertaining to virus-induced asthma exacerbations and consider recent advances in treatment options. Asthma is a chronic disease of the airways that continues to impose a substantial clinical burden worldwide. Asthma exacerbations, characterised by an acute deterioration in respiratory symptoms and airflow obstruction, are associated with significant morbidity and mortality. These episodes are most commonly triggered by respiratory virus infections. The mechanisms underlying the pathogenesis of virus-induced exacerbations have been the focus of extensive biomedical research. Developing a robust understanding of the interplay between respiratory viruses and the host immune response will be critical for developing more efficacious, targeted therapies for exacerbations. CONCLUSION: There has been significant recent progress in our understanding of the mechanisms underlying virus-induced airway inflammation in asthma and these advances will underpin the development of future clinical therapies.
AU - Kumar,K
AU - Singanayagam,A
AU - Johnston,SL
DO - 10.5644/ama2006-124.292
EP - 143
PY - 2020///
SP - 130
TI - Respiratory Virus Infections in Asthma: Research Developments and Therapeutic Advances.
T2 - Acta Med Acad
UR - http://dx.doi.org/10.5644/ama2006-124.292
UR - https://www.ncbi.nlm.nih.gov/pubmed/33189119
VL - 49
ER -